Other Fusion of Spine, Cervical Region Clinical Trial
Official title:
Enhanced Recovery After Surgery in Elderly Patients: Effects of Sugammadex on Recovery After Anterior Cervical Spine Surgery
Elderly patients are subjected to airway and other complications after cervical spine surgeries. The study aim to investigate the efficacy of sugammadex (vs. neostigmine) in the recovery after anterior cervical spine surgery.
Cervical spine surgeries have been increasing for many years. In Taiwan, according to the
data published by the Department of Statistics, Ministry of the Interior, the elderly
population (≥ 65 years old) increased and comprised 14.4% of the whole population in March,
2018. The percentages is likely to rise to 20% after 8 years. Because cervical spine surgery
is a procedure commonly performed in elderly patients, the increasing trend of cervical spine
surgery will likely continue. Elderly patients experienced an increased odds of length of
stay ≥ 5 days, pulmonary complications, cardiac compilations, venous thromboembolism, UTI,
sepsis, and unplanned readmission after anterior cervical spine surgeries according to the
literature. For example, in patients ≥ 65 years old undergoing cervical spine surgery, 9.80%
patients experienced at least 1 complication or death. Patients of 70~74 years old (odds
ratio [OR] =1.94, 95% confidence interval [CI] = 1.03~3.65) and patients with at least 1
postoperative complication (OR 9.59, 95% CI 5.17~17.80) had increased risks of unplanned
readmissions. Patients ≥ 75 years old were at higher risk of developing a complication or
death with an odds ratio (OR 1.72, 95% CI 1.13~2.61). Identification of factors and change
the policy of standard care in elderly patients can improve surgical outcome. The elderly
have a different physiological change, such as lower elimination of the anesthetics,
resulting in the confusion or delaying of detecting complications after the surgery.
Airway complications after ACCS are not uncommon. This includes sorethroat, vocal cord
paresis without overt symptoms, vocal cord palsy or dysphonia, and dysphagia. The incidence
of voice and swallowing complaints is primarily published in the spine literature and is
inconsistent with rates ranging between 0.4% and 71%. The discrepancy may result from
differences in the measurements and timepoints. We have performed a preliminary observational
study investigating postoperative dysphonia and dysphagia after anterior cervical spine
surgeries. We demonstrated more patients score none or mild dysphonia after surgeries in
groups receiving sugammadex as a reversal of muscle relaxants. Suggammadex is a unique
neuromuscular reversal drug; modified γ-cyclodextrin that allows binding encapsulation of
rocuronium. The rocuronium molecule (a modified steroid) bound within sugammadex's lipophilic
core, is rendered unavailable to bind to the acetylcholine receptor at the neuromuscular
junction and results in the revesal of the effect of neuromuscular blackade. As the
preliminary observation was not a randomized, blinded study, whether sugammadex posses
beneficial effect on postoerative dysphonia warrants investigation.
Enhanced Recovery After Surgery (ERAS) proposes a multimodal, evidence-based approach to
perioperative care. The first goal of ERAS is the improvement of surgical outcomes and
patient experience, with a final impact on a reduction in the hospital length of stay (LOS).
The implementation of ERAS in spinal surgery is in the early stages. We believe the elements
for ERAS should direct to the specific characteristics of surgery and surgical population.
Therefore, our investigation for improving posteropative dyshonia and dysphagia will provide
a important reference for choice of elements for ERAS of cervical spine surgeries in the
future.
;